
### [NCIT:C4758](http://purl.obolibrary.org/obo/NCIT_C4758)
**Label:** Metastatic Malignant Neoplasm in the Liver

**Subclasses:** [NCIT:C36309](http://purl.obolibrary.org/obo/NCIT_C36309) (Colon Carcinoma Metastatic in the Liver), [NCIT:C96767](http://purl.obolibrary.org/obo/NCIT_C96767) (Metastatic Carcinoma in the Liver), [NCIT:C36302](http://purl.obolibrary.org/obo/NCIT_C36302) (Breast Carcinoma Metastatic in the Liver), [NCIT:C36306](http://purl.obolibrary.org/obo/NCIT_C36306) (Lung Carcinoma Metastatic in the Liver), 

**Class expressions from DL-Learner:**

- [UBERON:0006925](http://purl.obolibrary.org/obo/UBERON_0006925) (digestive system gland) 57.14%
- [UBERON:0002423](http://purl.obolibrary.org/obo/UBERON_0002423) (hepatobiliary system) 57.14%
- [UBERON:0002107](http://purl.obolibrary.org/obo/UBERON_0002107) (liver) 57.14%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 57.14%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 57.14%
- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 57.14%
- Thing 52.12%
- [UBERON:0003703](http://purl.obolibrary.org/obo/UBERON_0003703) (extrahepatic bile duct) 26.04%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 24.53%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 24.07%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 24.06%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 24.06%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 23.89%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 23.89%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 23.19%


